Granted Patent
B2
US 9,376,400 · App. 14/325,248 · Granted Jun 28, 2016
Process for the synthesis of triazoles
Inventors:
Shili Chen (Cheshire, CT); Rongliang Lou (Cheshire, CT); Yusheng Wu (New Haven, CT); Jiacheng Zhou (Newark, DE); Roger Hanselmann (Branford, CT)
Assignee:
MELINTA THERAPEUTICS, INC.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to processes for the preparation of triazoles. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.
Claims (3)
1. A compound corresponding to the structure
or a pharmaceutically acceptable salt thereof, wherein each R 20 is independently C 1 -C 6 alkyl or —O—(C 1 -C 6 alkyl).
2. A compound according to claim 1 , wherein each R 20 is methyl.
Assignments (7)
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT (PATENTS) AT REEL 054836 AND FRAME 0824, REEL 061314 AND FRAME 0572 AND REEL 068260 AND FRAME 0283
Recorded Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 074576/0471 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded Aug 25, 2022
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 061314/0572 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded Dec 22, 2020
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 054836/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 16, 2019
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 048030/0489 →
SECURITY INTEREST
Recorded Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 19, 2016
From: CHEN, SHILI; LOU, ROBGLIANG; WU, YUSHENG; ZHOU, JIACHENG; HANSELMANN, ROGER
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 038643/0448 →
CHANGE OF NAME
Recorded May 19, 2016
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 038754/0970 →
Continuity (4)
Continuation
11921838
Provisional Application
60688990
· Jun 8, 2005